UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pericytes and vessel maturation during tumor angiogenesis and metastasis

American journal of hematology, 2010-08, Vol.85 (8), p.593-598

2010

Volltextzugriff (PDF)

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

The lancet oncology, 2012-05, Vol.13 (5), p.539-548

2012

Volltextzugriff (PDF)

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies

British journal of cancer, 2023-03, Vol.128 (5), p.783-792

2023

Volltextzugriff (PDF)

Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling

Cell reports (Cambridge), 2019-12, Vol.29 (11), p.3472-3487.e4

2019

Volltextzugriff (PDF)

CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma

Pigment cell and melanoma research, 2011-12, Vol.24 (6), p.1148-1157

2011

Volltextzugriff (PDF)

Profound impairment of adaptive immune responses by alkylating chemotherapy

The Journal of immunology (1950), 2013-06, Vol.190 (12), p.6259-6268

2013

Volltextzugriff (PDF)

Inhibition of mesothelin as a novel strategy for targeting cancer cells

PloS one, 2012-04, Vol.7 (4), p.e33214-e33214

2012

Volltextzugriff (PDF)

Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome

PloS one, 2015-07, Vol.10 (7), p.e0133266-e0133266

2015

Volltextzugriff (PDF)

Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4436-4441

2011

Volltextzugriff (PDF)

Markers of endothelial glycocalyx dysfunction in Clarkson disease

Journal of translational medicine, 2022-08, Vol.20 (1), p.1-380, Article 380

2022

Volltextzugriff (PDF)

Phase II Study of Amrubicin As Second-Line Therapy in Patients With Platinum-Refractory Small-Cell Lung Cancer

Journal of clinical oncology, 2010-05, Vol.28 (15), p.2598-2603

2010

Volltextzugriff (PDF)

First in Human Phase I Trial of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Cancer

Clinical cancer research, 2007-12, Vol.13 (23), p.7119-7125

2007

Volltextzugriff (PDF)

The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy

International Journal of Breast Cancer, 2016-01, Vol.2016 (2016), p.103-110

2016

Volltextzugriff (PDF)

MARCKS is marked in combating lung cancer growth and acquired resistance

American journal of respiratory and critical care medicine, 2014-11, Vol.190 (10), p.1084-1086

2014

Volltextzugriff (PDF)

MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC

Thoracic cancer, 2022-11, Vol.13 (21), p.3032-3041

2022

Volltextzugriff (PDF)

A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates

American journal of clinical oncology, 2012-08, Vol.35 (4), p.386-392

2012

Volltextzugriff (PDF)

Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299

JTO clinical and research reports, 2023-12, Vol.4 (12), p.100584-100584, Article 100584

2023

Volltextzugriff (PDF)

Mechanisms limiting distribution of the threonine-protein kinase B-RaF(V600E) inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases

The Journal of pharmacology and experimental therapeutics, 2013-03, Vol.344 (3), p.655

2013

Volltextzugriff (PDF)

Single-institution Outcome of High-dose Interleukin-2 (HD IL-2) Therapy for Metastatic Melanoma and Analysis of Favorable Response in Brain Metastases

Anticancer research, 2009-10, Vol.29 (10), p.4189-4193

2009

Volltextzugriff (PDF)

Bisphosphonate-Related Osteonecrosis of the Jaw: Clinical Features, Risk Factors, Management, and Treatment Outcomes of 26 Patients

Journal of oral and maxillofacial surgery, 2009-09, Vol.67 (9), p.1904-1913

2009

Volltextzugriff (PDF)

Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma

Journal of Immunotherapy and Precision Oncology, 2024-02, Vol.7 (1), p.1-6

2024

Volltextzugriff (PDF)

Correction: Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome

PloS one, 2015-09, Vol.10 (9), p.e0137373-e0137373

2015

Volltextzugriff (PDF)

A Novel Reduced Immunogenicity Bispecific Targeted Toxin Simultaneously Recognizing Human Epidermal Growth Factor and Interleukin-4 Receptors in a Mouse Model of Metastatic Breast Carcinoma

Clinical cancer research, 2009-10, Vol.15 (19), p.6137-6147

2009

Volltextzugriff (PDF)

Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines

Journal of bone and joint surgery. American volume, 2010-01, Vol.92 (1), p.162-168

2010

Volltextzugriff (PDF)

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(173)

Publikationsform

Sprache

Englisch
(192)

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(122)
Humans
(101)
Oncology
(88)
Male
(63)
Female
(58)
Middle Aged
(49)
Adult
(39)
Aged
(36)
Biological And Medical Sciences
(31)
Animals
(29)
Medical Sciences
(29)
Treatment Outcome
(25)
Tumors
(24)
Lung Neoplasms - Drug Therapy
(23)
Mice
(23)
Aged, 80 And Over
(22)
Antineoplastic Agents - Therapeutic Use
(17)
Lung Neoplasms - Pathology
(17)
Neoplasm Staging
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pericytes and vessel maturation during tumor angiogenesis and metastasis

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies

Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling

CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma

Profound impairment of adaptive immune responses by alkylating chemotherapy

Inhibition of mesothelin as a novel strategy for targeting cancer cells

Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome

Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study

Markers of endothelial glycocalyx dysfunction in Clarkson disease

Phase II Study of Amrubicin As Second-Line Therapy in Patients With Platinum-Refractory Small-Cell Lung Cancer

First in Human Phase I Trial of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Cancer

The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy

MARCKS is marked in combating lung cancer growth and acquired resistance

MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC

A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates

A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses

Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299

Mechanisms limiting distribution of the threonine-protein kinase B-RaF(V600E) inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases

Single-institution Outcome of High-dose Interleukin-2 (HD IL-2) Therapy for Metastatic Melanoma and Analysis of Favorable Response in Brain Metastases

Bisphosphonate-Related Osteonecrosis of the Jaw: Clinical Features, Risk Factors, Management, and Treatment Outcomes of 26 Patients

Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma

Correction: Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome

A Novel Reduced Immunogenicity Bispecific Targeted Toxin Simultaneously Recognizing Human Epidermal Growth Factor and Interleukin-4 Receptors in a Mouse Model of Metastatic Breast Carcinoma

Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines

Suchergebnisse filtern